Whats Hot Today: TheStreet, Inc. (NASDAQ:TST), Bankrate, Inc. (NYSE:RATE), International Business Machines Corporation (NYSE:IBM), Conatus Pharmaceuticals Inc.

On 23 February, TheStreet, Inc. (NASDAQ:TST) announced that its Board of Directors had appointed Chairman Lawrence “Larry” S. Kramer as interim President and Chief Executive Officer. This appointment follows the resignation of Elisabeth DeMarse as the Company’s President and Chief Executive Officer and member of the Board of Directors.

TheStreet, Inc. (NASDAQ:TST) belongs to Technology sector. Its net profit margin is -4.90% and weekly performance is -18.75%. On last trading day company shares ended up at $0.91. TheStreet, Inc. (NASDAQ:TST) distance from 50-day simple moving average (SMA50) is 0.28%.

Bankrate, Inc. (NYSE:RATE) reported financial results for the quarter and full year ended December 31, 2015. Mobile represented 49% of CreditCards.com’s total consumer inquiries in the quarter and 22% of CreditCards.com’s total consumer inquiry revenue.

Bankrate, Inc. (NYSE:RATE) shares increased 1.65% in last trading session and ended the day at $7.40. RATE Gross Margin is 44.20% and its return on assets is -0.60%. Bankrate, Inc. (NYSE:RATE) quarterly performance is -49.76%.

International Business Machines Corporation (NYSE:IBM) will begin trading ex-dividend on February 08, 2016. A cash dividend payment of $1.3 per share is scheduled to be paid on March 10, 2016. Shareholders who purchased IBM prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 4th quarter that IBM has paid the same dividend.

International Business Machines Corporation (NYSE:IBM) belongs to Technology sector. Its net profit margin is 16.10% and weekly performance is -0.79%. On last trading day company shares ended up at $132.03. International Business Machines Corporation (NYSE:IBM) distance from 50-day simple moving average (SMA50) is 2.09%.

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company’s emricasan development program for the treatment of liver cirrhosis caused by nonalcoholic steatohepatitis (NASH).

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) shares increased 5.62% in last trading session and ended the day at $1.88. CNAT return on assets is -57.10%. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) quarterly performance is -40.88%.

FedEx Co. (NYSE:FDX)‘s stock had its “buy” rating reaffirmed by stock analysts at Cowen and Company in a report issued on Wednesday, AnalystRatings.NET reports.

FedEx Corporation (NYSE:FDX) shares increased 1.03% in last trading session and ended the day at $137.38. FDX Gross Margin is 71.00% and its return on assets is 3.30%. FedEx Corporation (NYSE:FDX) quarterly performance is -15.67%.

Leave a Reply

Your email address will not be published. Required fields are marked *